Toward rigorous control conditions in trials of digital therapeutics
- 25 October 2025
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 101, 1-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Approved trends and product characteristics of digital therapeutics in four countriesnpj Digital Medicine, 2025
- Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric DisordersJAMA Psychiatry, 2025
- The promise and challenges of mHealth in psychiatry: Bridging the gap between potential and long-awaited implementationEuropean Neuropsychopharmacology, 2025
- Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella reviewMolecular Psychiatry, 2024
- App-Based Interventions for Moderate to Severe DepressionJAMA Network Open, 2023
- Challenges With the Use of Digital Sham: Systematic Review and RecommendationsJournal of Medical Internet Research, 2023
- Effect of Engagement With Digital Interventions on Mental Health Outcomes: A Systematic Review and Meta-AnalysisFrontiers in Digital Health, 2021
- Induction of Efficacy Expectancies in an Ambulatory Smartphone-Based Digital Placebo Mental Health Intervention: Randomized Controlled TrialJMIR mHealth and uHealth, 2021
- Efficacy of treatments for anxiety disordersInternational Clinical Psychopharmacology, 2015